Hillrom is working to significantly ramp up production of its respiratory and critical care products to meet demand from the COVID-19 epidemic. The company says its goal is to more than double capacity in the following areas:
- Respiratory health, especially Life2000, a noninvasive ventilator currently approved in the US that is portable, lightweight and ideal for treating patients with mild to moderate respiratory distress across various acute care settings, including the emergency department, med-surg and post-ventilator weaning support. Expanded use of non-invasive ventilation can free up capacity for invasive ventilators for the most serious COVID-19 patients. Hillrom is working to increase its production capacity of Life2000 five-fold on an annualized basis.
- ICU and med-surg unit smart beds, including the company’s Progressa ICU bed, Centrella Smart+ bed, and, for international markets, the Hillrom 900 and Hillrom 900 Accella.
- Patient monitoring and diagnostics, including the company’s Connex and Spot Vital Signs monitors as well as physical assessment tools and consumables, including thermometry, probe covers and blood pressure devices and cuffs.
“We are committed to scaling production as rapidly as we can to meet the challenges the world is facing with COVID-19,” said Hillrom President and CEO John Groetelaars. “Hillrom’s critical care, vitals monitoring and respiratory products can help caregivers and patients as coronavirus continues to cause severe illness around the world. We are focused on our employees’ health and safety, and on ensuring that our products are available when and where our customers and patients need them.”
More information is available on the company’s website.